Abstract
There are many parasitic infections of medical importance, which can produce both systemic disease as well as skin lesions. For the most part, treatment of these infections in the elderly does not differ very much from that of younger patients. However, one must be aware that the geriatric population can present with certain challenges with regard to diagnosis of these diseases because history taking may be more difficult and patients often already have a set of other medical problems, which may overshadow the skin lesions. In addition, the clinical manifestations of these infections may not appear classical and may be altered. Dosages of drugs used to treat these infections, even topical agents, may require adjustments in this population. The recognition of scabies in elderly people living together is important and early treatment with topical scabiecides, including oral ivermectin, will help to control the spread of the infestation. Pediculosis may be a cause of pruritus in the elderly and can be treated with malathione, lindane or permethrin. Less common parasitic infections in the elderly, including cutaneous larva migrans and cutaneous leishmaniasis, present with a characteristic clinical picture and can be effectively treated with oral thiabendazole and intravenous antimonials.
Similar content being viewed by others
References
Meinking TL. Infestations. Curr Probl Dermatol 1999; 11(3): 73–120
Elgart ML. Current treatments for scabies and pediculosis. Skin Ther Lett 1999; 5(1): 1–3
Franz TJ, Lehman PA, Franz SF, et al. Comparative percutaneous absorption of lindane and permethrin. Arch Dermatol 1996; 132: 901–5
Meinking TL, Taplin D. Advances in pediculosis, scabies, and other mite infestations. Adv Dermatol 1990; 5: 131–52
Barkwell R, Shields S. Death after ivermectin treatment. Lancet 1997; 349: 1144–5
Diazgranados JA, Costa JL. Deaths after ivermectin treatment [letter]. Lancet 1997; 349: 1698
Dannaoui E, Kiazand A, Piens M, et al. Use of ivermectin for the management of scabies in a nursing home. Eur J Dermatol 1999; 9(6): 443–5
Marples MJ. The ecology of the skin. Springfield (IL): Charles C. Thomas, 1965
Katz R, Ziegler J, Blank H. The natural course of creeping eruption and treatment with thiabendazole. Arch Dermatol 1975; 91: 402–4
Drugs for parasitic infections. Med Lett Drugs Ther 1992; 34: 17–26
Bryceson ADM, Hay RJ. Parasitic worms and protozoa. In: Champion RH, Burton JL, Ebling FJG, editors. Textbook of dermatology. Oxford: Blackwell, 1991: 1239–40
Ashford RW, Desjeux P, De Raat P. Estimation of population at risk of infection with leishmaniasis. Parasitol Today 1991; 8: 104–5
Dowlati Y. Cutaneous leishmaniasis. Clin Dermatol 1996; 14: 425–31
Dowlati Y. Treatment of cutaneous leishmaniasis (Old World). Clin Dermatol 1996; 14: 513–7
Bryceson ADM. Diffuse cutaneous leishmanisis. II. Treatment. Trans R Soc Trop Med Hyg 1970; 64: 369–79
Martinez S, Marr JJ. Allopurinol in the treatment of American cutaneous leishmaniasis. N Engl J Med 1992; 326: 741–4
Saenz RE, Paz H, Berman JD. Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis. Am J Med 1990; 89: 147–55
El-On J, Halevy S, Grunwald MH, et al. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study. J Am Acad Dermatol 1992; 27: 227–31
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tan, HH., Goh, CL. Parasitic Skin Infections in the Elderly. Drugs & Aging 18, 165–176 (2001). https://doi.org/10.2165/00002512-200118030-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-200118030-00002